A detailed history of Resolute Wealth Strategies, LLC transactions in Eli Lilly & CO stock. As of the latest transaction made, Resolute Wealth Strategies, LLC holds 1,058 shares of LLY stock, worth $877,864. This represents 0.55% of its overall portfolio holdings.

Number of Shares
1,058
Previous 1,037 2.03%
Holding current value
$877,864
Previous $806 Million 18.78%
% of portfolio
0.55%
Previous 0.49%

Shares

5 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Aug 13, 2024

BUY
$724.87 - $909.04 $15,222 - $19,089
21 Added 2.03%
1,058 $958 Million
Q1 2024

May 14, 2024

BUY
$592.2 - $792.28 $185,358 - $247,983
313 Added 43.23%
1,037 $806 Million
Q4 2023

Feb 06, 2024

BUY
$525.19 - $619.13 $24,683 - $29,099
47 Added 6.94%
724 $422 Million
Q3 2023

Nov 13, 2023

BUY
$434.7 - $599.3 $22,169 - $30,564
51 Added 8.15%
677 $364 Million
Q2 2023

Aug 08, 2023

BUY
$350.74 - $468.98 $219,563 - $293,581
626 New
626 $293 Million

Others Institutions Holding LLY

About ELI LILLY & Co


  • Ticker LLY
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 950,174,976
  • Market Cap $788B
  • Description
  • Eli Lilly and Company discovers, develops, and markets human pharmaceuticals worldwide. It offers Basaglar, Humalog, Humalog Mix 75/25, Humalog U-100, Humalog U-200, Humalog Mix 50/50, insulin lispro, insulin lispro protamine, insulin lispro mix 75/25, Humulin, Humulin 70/30, Humulin N, Humulin R, and Humulin U-500 for diabetes; and Jardiance, T...
More about LLY
Track This Portfolio

Track Resolute Wealth Strategies, LLC Portfolio

Follow Resolute Wealth Strategies, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Resolute Wealth Strategies, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Resolute Wealth Strategies, LLC with notifications on news.